DIN 02150670 — NEORAL 100 MG
NEORAL is a capsule of Cyclosporine marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Cyclosporine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02150670
- Brand name
- NEORAL
- Active ingredient
- Cyclosporine
- Strength
- 100 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Calcineurin-inhibitor immunosuppressant
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cyclosporine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02495813 | CYCLOSPORINE | 100 MG | CAPSULE | EDENBRIDGE PHARMACEUTICALS, LLC | DORMANT |
| 02495805 | CYCLOSPORINE | 25 MG | CAPSULE | EDENBRIDGE PHARMACEUTICALS, LLC | DORMANT |
| 02495821 | CYCLOSPORINE | 50 MG | CAPSULE | EDENBRIDGE PHARMACEUTICALS, LLC | DORMANT |
| 02237671 | NEORAL | 10 MG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02150697 | NEORAL | 100 MG | SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02150689 | NEORAL | 25 MG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02150662 | NEORAL | 50 MG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 00593257 | SANDIMMUNE I.V. | 50 MG | SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02242821 | SANDOZ CYCLOSPORINE | 100 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02247073 | SANDOZ CYCLOSPORINE | 25 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02247074 | SANDOZ CYCLOSPORINE | 50 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |